PPTDFPeptidream, Inc.
Price Chart
Loading chart...
About Peptidream, Inc. (PPTDF)
Peptidream, Inc. (PPTDF) is a Biotechnology company headquartered in Tokyo, Japan whose shares trade over-the-counter on the Pink tier.
PeptiDream Inc. is a biopharmaceutical company founded in 2006 employing our proprietary Peptide Discovery Platform System (PDPS), a state-of-the-art highly versatile discovery platform which enables the production of highly diverse (trillions) non-standard peptide libraries with high efficiency, for the identification of highly potent and selective hit candidates, which then can be developed into peptide-based, small molecule-based, or peptide-drug-conjugate-based therapeutics. PeptiDream aspires to be a world leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.
PPTDF key facts
- Ticker symbol
- PPTDF
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Tokyo, Japan
- Country of incorporation
- JP
- Year of incorporation
- 2006
- Employees
- 60
- Estimated market cap
- $775.27M (as of May 13, 2025)
- Shares outstanding
- 57,300,000
- Reporting standard
- International Reporting: Tokyo Stock Exchange
- Audit status
- Audited
- Fiscal year end
- 6/30
Peptidream, Inc. leadership
- Kiichi Kubota — President, CEO
- Patrick Reid — Senior VP, Research & Development
- Yoshiyuki Sekine — VP, Bus. Affairs
- Keiichi Masuya — Vice President
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with P
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Peptidream, Inc. (PPTDF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Company Officers
Social Media
Business Details
Stock Details
Loading modules...